AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studyInterventionalTrial registry record – peer review not applicable
Investigating Postural Stability in Multiple Sclerosis and Other Conditions Using a 3D Device
The study aims to evaluate the impact of a 3D postural device on posturometry in participants aged 18 to 80 with stroke, Parkinson's, or multiple sclerosis. It enrolled an estimated 151 people, followed for 3 weeks, although no results have been reported yet.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
This plain-English summary was written by AI from a trial registry record and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
- Human efficacy
- Not established from this source
- Mechanism
- Other
- Evidence strength
- No results yet
- Outcome
- Not reported
Why it matters
This research is important as it addresses rehabilitation for movement disorders in various neurological conditions, which can significantly affect quality of life.
What this does not prove
No results are posted; thus, conclusions cannot be drawn regarding the efficacy or impact of the intervention. Planned endpoints are not findings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Interventional
- Participants / samples
- 151 · estimated
- Randomised
- No
- Controlled
- No
- Primary endpoint met
- Not reported
- Relevant MS type
- All
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Neuroinflammation, Neuroprotection, Rehabilitation
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- people; ages from 18 Years to 80 Years; sex All
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
Supporting passages (18)
relevant ms typesConditions: Stroke; PARKINSON DISEASE (Disorder); Multiple Sclerosis
study phasePhase: Not applicable
study designStudy type: Interventional
subjectsParticipants: people; ages from 18 Years to 80 Years; sex All
speciesParticipants: people; ages from 18 Years to 80 Years; sex All
sample sizeEnrollment: 151 participants (estimated)
sample size basisEnrollment: 151 participants (estimated)
randomizedAllocation: Non randomized
peer reviewedTrial registry record.
research categoriesInterventions: Stroke posturo/3D group; Parkinson posturo/3D group; Multiple sclerosis posturo/3D group
interventionInterventions: Stroke posturo/3D group; Parkinson posturo/3D group; Multiple sclerosis posturo/3D group
primary endpointPrimary endpoints: Posturometry
follow upFollow-up: 3 weeks
limitationsNo results are posted. Planned enrolment and endpoints are not findings.
mechanisms"eligibilityCriteria": "Exclusion criteria:\n\n* multiple strokes in the medical history\n* systolic blood pressure less than 120 or greater than 160 mmHg\n* orthostatic hypotension\n* carotid artery stenosis\n* severe heart disease\n* hemophilia\n* traumatic brain injury\n* seizure disorder\n* untreated diabetes\n* abnormal electroencephalography\n* Mini Mental Test score \\< 22\n* abnormal blood panel\n* use of sedatives\n* irregular medication\n* severe aphasia (Western Aphasia Battery ≤ 25)\n* severe vision or hearing impairment\n* severe sensory dysfunction\n* severe orthopedic problem\n* other neurological condition affecting motor functions\n* current acute or subacute phase of the disease\n* alcoholism, drug use\n* smoking after stroke diagnosis\n* inability to understand verbal instructions or signals on a television screen\n* current participation in an individual or group exercise program in addition to standard physiotherapy\n* unable to walk at least 10 meters independently\n\nInclusion criteria:\n\n* patients with a first-time stroke\n* or Parkinson's disease\n* or multiple sclerosis\n* diagnosed by CT or MRI scan by a neurologist\n* exclusively chronic patients\n* mobility and postural difficulties as determined by a modified Rankin scale score (≥ 2).",
populationParticipants: people; ages from 18 Years to 80 Years; sex All
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
controlledIntervention model: Single group
AI assessment, not yet reviewed by a person · version 3 · Community votes are separate from evidence review.